QID 38912

Date Published: 2023-10-23

QID 38912: Cisco TelePresence Video Communication Server Command Injection Vulnerability (cisco-sa-expressway-injection-X475EbTQ)

A vulnerability in the web-based management interface of Cisco Expressway Series and Cisco TelePresence Video Communication Server (VCS) could allow an authenticated, remote attacker with read-write privileges on the application to perform a command injection attack that could result in remote code execution on an affected device.

Affected Products
Cisco TelePresence VCS Release prior to version 14.3.1

QID Detection Logic (Unauthenticated):
The check matches version of Cisco TelePresence Video Communication Server on the exposed banner information under the SIP banner.

Note: This is banner based detection and cannot check for a workaround, hence QID is kept as practice.

However, an attacker with read-write privileges on the application could enable this feature to carry out the exploit.

CVSS V3 rated as High - 7.2 severity.

CVSS V2 rated as Critical - 8.3 severity.

Solution

Customers are advised to refer to cisco-sa-expressway-injection-X475EbTQ for more information.

Vendor References

cisco-sa-expressway-injection-X475EbTQ - sec.cloudapps.cisco.com/security/center/content/CiscoSecurityAdvisory/cisco-sa-expressway-injection-X475EbTQ

CVEs related to QID 38912

CVE-2023-20209 |

Software Advisories

Advisory ID	Software	Component	Link
cisco-sa-expressway-injection-X475EbTQ			sec.cloudapps.cisco.com/security/center/content/CiscoSecurityAdvisory/cisco-sa-expressway-injection-X475EbTQ

By selecting these links, you may be leaving CVEreport webspace. We have provided these links to other websites because they may have information that would be of interest to you. No inferences should be drawn on account of other sites being referenced, or not, from this page. There may be other websites that are more appropriate for your purpose. CVEreport does not necessarily endorse the views expressed, or concur with the facts presented on these sites. Further, CVEreport does not endorse any commercial products that may be mentioned on these sites. Please address comments about any linked pages to [email protected].